Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

Menarini acquires a facility which represents Italian excellence in the sector of pharmaceutical active ingredients

 

PRESS RELEASE

 

 

 

An agreement for the sale to Menarini of the Casaletto Lodigiano facility owned by Euticals, a leader in the production of pharmaceutical active ingredients, was signed today.

Closure of the production site near Lodi has been avoided and a future has been guaranteed for the workers: an investment of 10 million euro is planned for the development and relaunch of the facility, which represents Italian excellence in fine chemicals. It will be complementary to the Menarini plants of Pisa and Lomagna, and will serve to produce high-quality active ingredients destined for strategic products.

 

 

Menarini acquires a facility which represents Italian excellence in the sector of pharmaceutical active ingredients

 

 

Florence, 23 May 2016 – Menarini continues to believe and invest in Italia and just two months after the creation of VaxYnethic, a joint venture with BiosYnth, an Italian company that is a pioneer in the field of biopharmaceutical production, today it has signed an agreement for the acquisition of the Lodichem (formerly Euticals) facility in Casaletto Lodigiano, a small Italian “jewel” in the production of pharmaceutical active ingredients. The plant, capable of producing active and intermediate ingredients, will work in synergy alongside the other Menarini chemical plants situated in Pisa and Lomagna, and will be expanded and improved thanks to an investment of 10 million euro.

The project involves the construction of a new building for offices and quality-control laboratories, as well the refurbishing of numerous systems.

 

"We believe strongly in this acquisition, confirming our obsessive attention to the quality of medicines. Italy has a great tradition in this sense, recognised worldwide, and at Menarini we are always proud when we manage to carry out the entire production process of a medicine in our own country. In addition, this acquisition makes it possible to save and develop a facility which otherwise was destined to close. At the same time, it represents a great opportunity for growth, with a view to promoting and relaunching examples of excellence at the regional level, recognising Italian chemistry as a strategic and leading sector for our Group" said Lucia Aleotti and Alberto Giovanni Aleotti, Chairperson and Deputy Chairperson of Menarini.